Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China · Delayed Price · Currency is CNY 5.66
-0.13 (-2.25%)
May 20, 2026, 12:25 PM CST
SHE:002099 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -76.54 | -93.75 | -330.27 | -420.06 | 88.01 | 95.23 |
Depreciation & Amortization | 341.15 | 341.15 | 342.54 | 364.6 | 336.52 | 294.23 |
Other Amortization | 1.58 | 1.58 | 1.79 | 1.17 | 0.46 | 0.26 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -1.04 | -12.88 | -0.29 | 1.48 |
Asset Writedown & Restructuring Costs | 115.78 | 115.78 | 242.85 | 132.82 | 60.16 | -0.55 |
Loss (Gain) From Sale of Investments | -55.82 | -55.82 | 27.68 | 83.92 | 27.27 | -9.8 |
Provision & Write-off of Bad Debts | - | - | 4.54 | -13.41 | 17.53 | 10.08 |
Other Operating Activities | 10.89 | 56.2 | 152.39 | 171.89 | -36.1 | 61.59 |
Change in Accounts Receivable | -163.71 | -163.71 | -340.3 | 2.74 | -229.76 | -754.98 |
Change in Inventory | -186.96 | -186.96 | -264.23 | 293.73 | -213.74 | -194.08 |
Change in Accounts Payable | -77.68 | -77.68 | 347.63 | -316.52 | 67.64 | 601.96 |
Operating Cash Flow | -87.77 | -59.68 | 174.83 | 240.54 | 116.09 | 102.36 |
Operating Cash Flow Growth | - | - | -27.32% | 107.19% | 13.41% | -80.83% |
Capital Expenditures | -65.59 | -74.46 | -122.11 | -153.08 | -179.42 | -229.56 |
Sale of Property, Plant & Equipment | 9.26 | 9.25 | 8.09 | 24.34 | 5.66 | 9.23 |
Divestitures | - | - | - | - | - | 0.16 |
Investment in Securities | -13.28 | -13.28 | 24 | -40.5 | -459.13 | -254 |
Other Investing Activities | -105.66 | 386.12 | -437.37 | 41.03 | 12.58 | -34.84 |
Investing Cash Flow | -175.28 | 307.63 | -527.39 | -128.21 | -620.32 | -509.01 |
Long-Term Debt Issued | - | 2,453 | 2,507 | 2,307 | 2,228 | 1,069 |
Total Debt Issued | 1,913 | 2,453 | 2,507 | 2,307 | 2,228 | 1,069 |
Long-Term Debt Repaid | - | -2,391 | -2,591 | -2,321 | -1,822 | -934.76 |
Total Debt Repaid | -2,354 | -2,391 | -2,591 | -2,321 | -1,822 | -934.76 |
Net Debt Issued (Repaid) | -441.08 | 61.49 | -84.56 | -14.51 | 406.11 | 134.24 |
Repurchase of Common Stock | - | - | -151.42 | - | - | - |
Common Dividends Paid | -25.79 | -26.29 | -28.06 | -118.94 | -195.44 | -53.45 |
Other Financing Activities | -24.29 | 67.83 | 267.5 | 232.52 | -332.55 | - |
Financing Cash Flow | -491.16 | 103.02 | 3.46 | 99.07 | -121.88 | 80.79 |
Foreign Exchange Rate Adjustments | -55.39 | -29.13 | 35.69 | 1.1 | 75.13 | -25.53 |
Net Cash Flow | -809.59 | 321.85 | -313.4 | 212.5 | -550.97 | -351.39 |
Free Cash Flow | -153.37 | -134.14 | 52.73 | 87.46 | -63.33 | -127.2 |
Free Cash Flow Growth | - | - | -39.72% | - | - | - |
Free Cash Flow Margin | -8.24% | -7.21% | 2.72% | 4.03% | -2.34% | -5.12% |
Free Cash Flow Per Share | -0.10 | -0.09 | 0.03 | 0.05 | -0.04 | -0.08 |
Cash Income Tax Paid | - | -34.97 | -36.96 | -19.73 | -88.14 | 9.28 |
Levered Free Cash Flow | 146.33 | 76.86 | 237.44 | 202.78 | 77.39 | 401.47 |
Unlevered Free Cash Flow | 146.33 | 76.86 | 255.44 | 226.38 | 100.23 | 415.15 |
Change in Working Capital | -424.78 | -424.78 | -265.66 | -67.52 | -377.46 | -350.16 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.